Nomifensine is a novel antidepressant used for the treatment of endogenous depression, bipolar depression, and anxious depression. It primarily acts by inhibiting the dopamine transporter. Nomifensine maleate, a tricyclic compound derived from 1,2,3,4-tetrahydroisoquinoline, inhibits the reuptake of dopamine and norepinephrine (NA), exhibiting therapeutic effects comparable to those of tricyclic antidepressants but with less cardiac depressant effects than amitriptyline.